Quick answers
- Does CP2D/AS-3 anticoagulant and additive system have a boxed warning?
- No. None of the 12 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of CP2D/AS-3 anticoagulant and additive system?
- The FDA drug shortage list shows “Current shortage” for a product of this medicine (updated October 19, 2026). Ask your pharmacist about alternatives.
- Has CP2D/AS-3 anticoagulant and additive system been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes CP2D/AS-3 anticoagulant and additive system?
- 2 companies list prescription products of CP2D/AS-3 anticoagulant and additive system in the FDA NDC Directory, including GVS TM Inc and B. Braun Medical Inc.
What CP2D/AS-3 anticoagulant and additive system is used for
We did not find an “Indications and Usage” section in the FDA labels for this medicine. See the label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 12 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Solution |
|---|---|
| Route | Intravenous |
| Prescription products | 8 in the FDA NDC Directory |
| Brand names | Leukotrap Wb System - CP2D, Leukotrap Rc Pl System, Leukotrap Rc System, Blood Collection System |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- GVS TM Inc12 products
- B. Braun Medical Inc.2 products
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA019626 DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE 2.5% IN PLASTIC CONTAINER, DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 7.7% IN PLASTIC CONTAINER, DEXTROSE 70% IN PLASTIC CONTAINER | B Braun | February 2, 1988 | 21, latest October 20, 2026 2026: Labeling · 2015: Manufacturing (CMC) · 2015: Manufacturing (CMC) |
Shortage status
Current shortage · updated October 19, 2026 · first posted February 14, 2022
| Product | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) |
|---|---|
| Availability | Available |
| Company | B. Braun Medical Inc. |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| SPL set ID of the quoted label | 42ece7e1-1da1-7e5a-e063-6294a90ac803 |
|---|---|
| FDA labels (SPL) | 12 |
| FDA applications | NDA019626 |
| Active ingredients (FDA) | DEXTROSE, UNSPECIFIED FORM |
Next steps
- Find a pharmacy near youAsk which price applies to you and whether your product is affected by a recall
- Latest FDA drug recallsAll medicines, newest first
- Leukotrap WB System - CP2DBrand page: products, maker and price
- Blood Collection SystemBrand page: products, maker and price
- Leukotrap RC PL SystemBrand page: products, maker and price
- Leukotrap RC SystemBrand page: products, maker and price
- GVS TM IncMaker or distributor
- B. Braun Medical Inc.Maker or distributor
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Leukotrap WB system - CP2D, Gvs Tm Inc, effective July 3, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →